Hernández V - Search Results

1

Urethral stricture in women. Morphofunctional diagnosis and treatment.

Gómez V, Hernández V, Capitan C, Carrera C, Sánchez M, De la Peña E, Llorente C. Gómez V, et al. Among authors: hernandez v. Arch Esp Urol. 2011 Mar;64(2):97-104. Arch Esp Urol. 2011. PMID: 21399242 Review.

2

[Results of active surveillance in low and intermediate risk prostate cancer].

Llorente C, Diaz Goizueta FJ, Hernandez V, de la Morena JM, de la Peña E. Llorente C, et al. Among authors: hernandez v. Arch Esp Urol. 2014 Jun;67(5):452-6. Arch Esp Urol. 2014. PMID: 24914844 Review. Spanish.

3

The role of ischemia in the deterioration of renal function after partial nephrectomy.

Arceo-Olaiz R, de la Morena JM, Hernandez V, Llorente C. Arceo-Olaiz R, et al. Among authors: hernandez v. Arch Esp Urol. 2013 May;66(4):350-8. Arch Esp Urol. 2013. PMID: 23676538 Review. English, Spanish.

4

Feasibility and safety of hospital discharge 24 hours after laparoscopic radical prostatectomy.

Díaz FJ, Hernández V, de la Peña E, Blázquez C, Martín M, Llorente C. Díaz FJ, et al. Among authors: hernandez v. Arch Esp Urol. 2013 Dec;66(10):931-8. Arch Esp Urol. 2013. PMID: 24369187 English, Spanish.

5

Incidence and prognosis of clinically significant incidental prostate cancer after radical cystectomy for bladder cancer.

Fernández-Conejo G, de la Peña E, Hernández V, Castro A, Pérez-Fernández E, Llorente C. Fernández-Conejo G, et al. Among authors: hernandez v. Arch Esp Urol. 2019 Nov;72(9):915-920. Arch Esp Urol. 2019. PMID: 31697251 Free article. English, Spanish.

6

[Recommendations on bladder cancer Management during COVID-19 pandemia: lessons learned and future plans.].

de la Peña E, Hernández V, Guijarro A, Castro A, Losa JE, Martel J, Aguilar E, Llorente C. de la Peña E, et al. Among authors: hernandez v. Arch Esp Urol. 2020 Jun;73(5):374-383. Arch Esp Urol. 2020. PMID: 32538807 Free article. Spanish.

7

GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.

Capitán C, Blázquez C, Martin MD, Hernández V, de la Peña E, Llorente C. Capitán C, et al. Among authors: hernandez v. Eur Urol. 2011 Oct;60(4):734-9. doi: 10.1016/j.eururo.2011.05.043. Epub 2011 Jun 1. Eur Urol. 2011. PMID: 21658839 Clinical Trial.

8

Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.

De La Peña E, Hernández V, Blázquez C, Martin MD, Díaz FJ, Capitán C, Alemany I, Llorente C. De La Peña E, et al. Among authors: hernandez v. BJU Int. 2013 Apr;111(4 Pt B):E196-201. doi: 10.1111/j.1464-410X.2012.11588.x. Epub 2012 Oct 26. BJU Int. 2013. PMID: 23106771

9

Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer.

Hernández V, Llorente C, de la Peña E, Pérez-Fernández E, Guijarro A, Sola I. Hernández V, et al. Urol Oncol. 2016 Apr;34(4):165.e19-23. doi: 10.1016/j.urolonc.2015.11.005. Epub 2015 Dec 10. Urol Oncol. 2016. PMID: 26687318

10

A comprehensive analysis of cost of an active surveillance cohort compared to radical prostatectomy as primary treatment for prostate cancer.

Pozo C, Hernández V, Capitán C, de la Peña E, Fernández-Conejo G, Martínez MDM, Del Riego S, Pérez-Fernández E, Llorente C. Pozo C, et al. Among authors: hernandez v. World J Urol. 2019 Jul;37(7):1297-1303. doi: 10.1007/s00345-018-2500-7. Epub 2018 Oct 1. World J Urol. 2019. PMID: 30276542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

743 results

Search Page